If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to ...

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how ...

The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...

1 than the original Spikevax. The 437-patient study – reported in June – compared a 50 µg booster dose of both vaccines on antibody levels one month after administration, with the new version ...

Yes, older Americans should get yet another COVID shot—but if you have already gotten the latest version, there's no rush.

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

The fall booster shot will protect against some of the latest strains of the virus, including JN. 1 and KP. 2, Health Canada ...

The Massachusetts-based company said that third-quarter revenue from its Spikevax shot came in at $1.8 billion, with $1.2 billion of the sales coming in the United States. The overall figure ...

Shares up nearly 5% to $54.22 in early trading Spikevax COVID vaccine sales reached $1.8 billion, beating expectations Moderna expects lower COVID vaccine sales this year compared to 2023 $10 ...

Fewer health care workers are getting the most recent COVID-19 booster. Findings from a new ... On top of this, COVID-19 vaccines were also commercialized in the fall of that year, potentially ...

That said, whether or not you're eligible for a COVID booster, you can still get a flu shot, and Dr. Souleles recommends ...

These mRNA vaccines use genetic instructions ... from 19 individuals over 28 days after receiving a Moderna SPIKEVAX mRNA booster immunisation. The team discovered key insights into the movement ...